Search Results 1201-1210 of 17067 for monoclonal antibody

1. Cancer Treatment Clinical Trials - Mayo Clinic Research

   ... Antibody Drug Conjugate, in Participants With Advanced Solid Tumors Rochester, MN. The purpose of this study is to evaluate the safety, tolerability ...

2. A Study to Assess the Effectiveness, Safety and Tolerability of Dupilumab in Patients with Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) with Type 2 Inflammation - Mayo Clinic

   Exposure to another investigative drug (small molecules as well as monoclonal antibodies) ... The minimum interval since exposure to any other (non-antibody) ...

3. Inebilizumab-cdon (intravenous route) - Mayo Clinic

   It is used in patients who are anti-aquaporin-4 (AQP4) antibody positive. This medicine is also used to treat immunoglobulin G4-related disease (IgG4-RD), a ...

4. Respiratory syncytial virus vaccine, adjuvanted (intramuscular route) - Mayo Clinic

   It works by causing your body to produce its own protection (antibodies) against the disease. Respiratory syncytial virus can cause serious breathing ...

5. Sharing Mayo Clinic: Back from the brink

   Mayo Clinic Laboratories' comprehensive approach to targeted antibody testing played a crucial and lifesaving role in moving Sheila Lewis to recovery from ...

6. A Study to Evaluate AFPᶜ³³²T in Advanced HCC - Mayo Clinic

   Prior cancer-directed immunotherapy within 4 weeks, including monoclonal antibodies against PD-1 receptor or ligand;; Use of an experimental vaccine within 2 ...

7. A Study of TAK-981 in Combination with Rituximab in Participants with Relapsed/Refractory (r/r) CD20-positive (CD20+) Non-Hodgkin Lymphoma (NHL) - Mayo Clinic

   iNHL (including FL of grades 1-3A and marginal zone lymphoma) refractory to rituximab or to any other anti-CD20 monoclonal antibodies ... Prior anti-CD20 antibody ...

8. A Study to Evaluate Induction Chemotherapy with ABVD Followed by Brentuximab Vedotin Consolidation in Previously-untreated, Non-bulky Stage I or II Hodgkin Lymphoma - Mayo Clinic

   For this research study, the use of brentuximab vedotin in newly diagnosed Hodgkin lymphoma is considered investigational. Brentuximab vedotin is an antibody ...

9. Overview - Rheumatology - Mayo Clinic Research

   Vasculitis — giant cell arteritis, anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis and all other forms of vasculitis. · Systemic autoimmune ...

10. A Study Evaluating the Safety and Effectiveness of JCAR017 to Treat Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) - Mayo Clinic

    Anti-CD20 monoclonal antibodies within 7 days prior to leukapheresis 11. Venetoclax within 4 days prior to leukapheresis 12. Idelalisib or duvelisib within ...